Study Name: PREvention of CardIovascular and DiabEtic kidNey disease in Type 2 Diabetes

Study Acronym: PRECIDENTD

Study PI(s): Brendan M. Everett, MD, MPH (Clinical Coordinating Center PI), Deborah J. Wexler, MD, MSc (Clinical Coordinating Center PI), Robert J. Glynn, ScD (Data Coordinating Center PI)

Purpose:The primary objective of PRECIDENTD is to compare rates of the total number of important cardiovascular, kidney, and death events among three alternative treatments for patients with type 2 diabetes and either established ASCVD or at high risk for ASCVD.

Study Sponsor: 

GPC Partners: 

1. 1. University of Texas SouthWestern Medical Center (UTSWMC)
   2. University of Missouri (UMO)
   3. Medical College of Wisconsin (MCW)